EBMT 2017 | Treatment methods in mantle cell lymphoma

Stephen Robinson

Dr. Stephen Robinson of the Bristol Hematology Oncology Centre discusses the treatment methods involved in mantle cell lymphoma (MCL). MCL is a type of non-Hodgkin lymphoma with a relatively poor prognosis. The first-line treatment in response to MCL is an autologous transplant, other treatments include allogeneic transplantation however, there is no definitive treatment plan. A large retrospective study with EBMT was carried out to investigate the efficacy of allogeneic transplantation in MCL and results suggest that it should not be used as a first-line treatment due to evidence of association with significant toxicity. Recorded at the 2017 annual meeting of the European Society for Blood and Marrow Transplantation

Share this video